{"id":"https://openalex.org/W2170379593","doi":null,"title":"Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria. URTILOR study group.","display_name":"Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria. URTILOR study group.","alternate_titles":[],"publication_year":2000,"publication_date":"2000-04-01","ids":{"openalex":"https://openalex.org/W2170379593","mag":"2170379593","pmid":"https://pubmed.ncbi.nlm.nih.gov/10725819"},"language":"en","primary_location":{"id":"pmid:10725819","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10725819","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of dermatology : EJD","raw_type":"Clinical Trial"},"parent_works":[],"lineage":["https://openalex.org/W2170379593"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012649423","display_name":"Fran\u00e7isque Leynadier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"F Leynadier","raw_affiliation_strings":["Sanofi-Synthelabo, 31, avenue Paul-Vaillant-Couturier, 92222 Bagneux Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi-Synthelabo, 31, avenue Paul-Vaillant-Couturier, 92222 Bagneux Cedex, France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018830418","display_name":"Claudia Duarte-Risselin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Duarte-Risselin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5059679584","display_name":"M. Murrieta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Murrieta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.0531,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":{"value":0.8459724,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"10","issue":"3","first_page":"205","last_page":"211"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12438","display_name":"Urticaria and Related Conditions","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12438","display_name":"Urticaria and Related Conditions","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10634","display_name":"Food Allergy and Anaphylaxis Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mizolastine","display_name":"mizolastine","score":0.996999979019165},{"id":"https://openalex.org/keywords/loratadine","display_name":"loratadine","score":1.0},{"id":"https://openalex.org/keywords/chronic-spontaneous-urticaria","display_name":"chronic spontaneous urticaria","score":1.0},{"id":"https://openalex.org/keywords/histamine-h1-receptor-antagonists","display_name":"histamine H1 receptor antagonists","score":0.925000011920929},{"id":"https://openalex.org/keywords/second-generation-antihistamines","display_name":"second-generation antihistamines","score":0.8550000190734863},{"id":"https://openalex.org/keywords/angioedema","display_name":"angioedema","score":0.8859999775886536},{"id":"https://openalex.org/keywords/skin-prick-test","display_name":"skin prick test","score":0.5139999985694885},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6859999895095825},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.4819999933242798},{"id":"https://openalex.org/keywords/onset-of-action","display_name":"onset of action","score":0.7200000286102295}],"concepts":[{"id":"https://openalex.org/C2780734495","wikidata":"https://www.wikidata.org/wiki/Q424049","display_name":"Loratadine","level":2,"score":0.997149646282196},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.879367470741272},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5251550078392029},{"id":"https://openalex.org/C2777995640","wikidata":"https://www.wikidata.org/wiki/Q1129007","display_name":"Angioedema","level":2,"score":0.49615201354026794},{"id":"https://openalex.org/C14184104","wikidata":"https://www.wikidata.org/wiki/Q1362526","display_name":"Visual analogue scale","level":2,"score":0.4924984872341156},{"id":"https://openalex.org/C10335311","wikidata":"https://www.wikidata.org/wiki/Q309513","display_name":"Histamine H1 receptor","level":4,"score":0.49118778109550476},{"id":"https://openalex.org/C1122143","wikidata":"https://www.wikidata.org/wiki/Q61233","display_name":"Histamine","level":2,"score":0.4836041033267975},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4773578643798828},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4121930003166199},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.2258245050907135},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07351410388946533}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006634","descriptor_name":"Histamine H1 Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006634","descriptor_name":"Histamine H1 Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014581","descriptor_name":"Urticaria","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017336","descriptor_name":"Loratadine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017336","descriptor_name":"Loratadine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:10725819","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10725819","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of dermatology : EJD","raw_type":"Clinical Trial"},{"id":"mag:2170379593","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10725819","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9907000064849854}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4253843486","https://openalex.org/W2155943775","https://openalex.org/W2377771057","https://openalex.org/W1508479020","https://openalex.org/W2386273670","https://openalex.org/W2070167969","https://openalex.org/W2356357361","https://openalex.org/W2391215675","https://openalex.org/W2393622823"],"abstract_inverted_index":{"Mizolastine,":[0],"a":[1,89,112,205,219,243,256],"new":[2],"second-generation":[3],"H1":[4],"receptor":[5],"antagonist":[6],"with":[7,13,125,153,213,218],"additional":[8],"anti-allergic":[9],"properties,":[10],"was":[11,149],"compared":[12,124,152],"loratadine":[14,43,132,155,225,232],"in":[15,63,82,145,245],"61":[16],"patients":[17,29,122],"suffering":[18],"from":[19,175],"severe":[20],"chronic":[21],"idiopathic":[22],"urticaria":[23],"(CIU).":[24],"In":[25,239],"this":[26],"double-blind":[27],"study,":[28],"were":[30,55,94],"randomly":[31],"allocated":[32],"to":[33,165,183,254],"receive":[34],"either":[35],"mizolastine":[36,75,106,147,193,223,241],"10":[37,44],"mg":[38,45],"(n":[39,46],"=":[40,47],"26)":[41],"or":[42],"35)":[48],"once-daily":[49],"for":[50,74,105,192,226],"28":[51],"days.":[52],"Both":[53],"compounds":[54],"well":[56],"tolerated,":[57],"safe":[58],"and":[59,72,76,79,100,107,134,174,194,211,231,237,252],"efficacious.":[60],"The":[61],"reduction":[62,81,137],"the":[64,80,83,131,135,139,146,154,171,189],"number":[65],"of":[66,121,130,138,143,208,216,222,259],"episodes":[67,144],"per":[68],"week":[69],"(5.":[70],"6+/-16.3":[71],"6.4+/-12.4":[73],"loratadine,":[77,108,195],"respectively)":[78],"symptom":[84],"severity":[85],"score,":[86],"measured":[87],"using":[88],"Visual":[90],"Analogue":[91],"Scale":[92],"(VAS),":[93],"comparable":[95],"(30.2":[96],"+/-":[97,102,159,167,177,185],"39.0":[98],"mm":[99,104],"30.5":[101],"28.5":[103],"respectively).":[109,196],"Mizolastine":[110,230],"had":[111],"positive":[113],"effect":[114],"on":[115,162,180,250],"angioedema":[116,251],"(85%":[117],"CI":[118],"95%":[119,128],"[0.69-1.00])":[120],"improved":[123],"75%":[126],"(CI":[127],"[0.59-0.91])":[129],"group":[133,148,156],"differential":[136],"mean":[140],"total":[141],"duration":[142],"higher":[150],"when":[151],"(from":[157],"13.7":[158],"33.5":[160],"hours":[161,169,179,187],"day":[163,181],"0":[164,182],"5.1":[166,184],"9.0":[168],"over":[170,188,224],"treatment":[172,190],"period":[173,191],"8.2":[176],"8.8":[178],"7.8":[186],"Prick":[197],"test":[198],"analysis":[199],"demonstrated":[200,242],"that":[201],"both":[202,233],"drugs":[203],"caused":[204],"significant":[206,220],"decrease":[207],"histamine-induced":[209],"wheal":[210],"flare":[212],"no":[214],"development":[215],"tolerance,":[217],"superiority":[221,244],"some":[227],"histamine":[228],"concentrations.":[229],"proved":[234],"very":[235],"efficacious":[236],"safe.":[238],"addition":[240],"prick":[246],"tests,":[247],"beneficial":[248],"effects":[249],"seemed":[253],"provide":[255],"faster":[257],"onset":[258],"action.":[260]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2170379593","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
